Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Currently trading with a volume of 3,803,131, the MRNA's price is down by -1.06%, now at $27.18. RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...

SHREVEPORT, La. - The U.S. Department of Health and Human Services has announced $500 million in funding cuts to vaccine ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future pandemics and innovations like cancer vaccines.

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

Research that helped develop mRNA vaccines won the Nobel Prize in Physiology or Medicine in 2023. Members of the scientific community are criticizing Kennedy for his decision.

A tremendous step backward, the politicization of science, and RFK Jr., who has been a lifelong anti-vaccine propagandist and ...

Research shows mRNA vaccines saved millions of lives during the COVID-19 pandemic. Now scientists are using that Nobel ...

Last Thursday, on the same day that Trump blitzed the world, yet again, with a new round of tariffs on a broad range of goods ...

The Trump administration canceled about $500 million for research into mRNA vaccines. The move slows progress in using the ...